<code id='E797918F0E'></code><style id='E797918F0E'></style>
    • <acronym id='E797918F0E'></acronym>
      <center id='E797918F0E'><center id='E797918F0E'><tfoot id='E797918F0E'></tfoot></center><abbr id='E797918F0E'><dir id='E797918F0E'><tfoot id='E797918F0E'></tfoot><noframes id='E797918F0E'>

    • <optgroup id='E797918F0E'><strike id='E797918F0E'><sup id='E797918F0E'></sup></strike><code id='E797918F0E'></code></optgroup>
        1. <b id='E797918F0E'><label id='E797918F0E'><select id='E797918F0E'><dt id='E797918F0E'><span id='E797918F0E'></span></dt></select></label></b><u id='E797918F0E'></u>
          <i id='E797918F0E'><strike id='E797918F0E'><tt id='E797918F0E'><pre id='E797918F0E'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:fashion    Page View:7739
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more
          Leqembi, other new Alzheimer’s drugs require better biomarkers
          Leqembi, other new Alzheimer’s drugs require better biomarkers

          AdobeTherecentFDAapprovalofLeqembi,thelatestanti-amyloiddrug,isundoubtedlyabreakthroughforthefield,p

          read more
          Anesthesiologist group: stop taking Ozempic before surgery
          Anesthesiologist group: stop taking Ozempic before surgery

          EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

          read more

          Lecanemab for Alzheimer's is coming. Is the health system ready?

          AneffectivetreatmentforAlzheimer’sdiseasehaslongbeenaholygrailinthepharmaceuticalindustry.InearlyJun